|
|
| Generic Drugs And Brand Lifecycle Strategies |
|
| Published : 2002/03 |
| The report focuses an overview of current trends and issues in the generic drug industry and both laws and policies that have come into dispute from both brand and generic companies ... |
| Autoimmune Disease Therapeutics Worldwide: Markets & Developments |
|
| Published : 2002/02 |
| This new study will answer your key market and R&D questions:
What new treatments have already reached market? Are in development? And what are the current and projected market sizes and shares for the treatments for each of these disorders? ... |
| Profiting from Proteomics: Entering the Age of High Throughput |
|
| Published : 2002/02 |
| This report covers the key areas in proteomics today, including new approaches to protein expression, evolving methods of studying protein function, new technologies such as protein chips, and advances in protein informatics ... |
| Emerging Markets in Total Knee Replacement |
|
| Published : 2002/01 |
| The report gives you access to key information regarding the populations, economies, and health care systems of ten different countries: China, India, South Korea, Taiwan, Czech Republic, Hungary, Poland, Argentina, Brazil, and Mexico. ... |
| Transfection and Gene Transfer: Technologies and Markets |
|
| Published : 2002/01 |
| This report focuses on the human gene transfer technology that is being developed, the options that the technologies present, and the progress being made in these fields. Gene transfer technology might have a major impact in the next five years, but long- ... |
| Commercialization of Genomics |
|
| Published : 2001/12 |
| Structural proteomics\determining the three-dimensional structures of
large numbers of proteins\has emerged as one of the most immediate-ly applicable tools for drug discovery and development. ... |
| High-Throughput Genomics |
|
| Published : 2001/12 |
| This report reviews leading companies and their high-throughput technologies in the following areas: gene sequencing, genotyping, gene expression monitoring, gene functional studies, proteomics, and genomic target identification and validation ... |
| Immunoassays: Technologies, Market |
|
| Published : 2001/11 |
| According to this study the worldwide sales of immunoassays in the clinical, food safety, and environmental testing fields is estimated at $15.5 billion in 2001. ... |
| Market for Advanced Wound Care Technologies |
|
| Published : 2001/10 |
| The market for advanced wound care products has been rapidly evolving over the past 25 years and has recently entered a new phase with the introduction of several sophisticated products based on biotechnology and biomaterials science ... |
| Drug Delivery Technologies |
|
| Published : 2001/09 |
| This report captures the insights and expertise contained in presentations by drug delivery technology industry leaders at three conferences organized by The Center for Business Intelligence ... |
| The Growing Food Testing Business: Pathogens, Pesticides, GMO |
|
| Published : 2001/09 |
| Americans have the safest food supply in the world, yet the Centers for Disease Control (CDC) estimates that each year there are an estimated 76 million illnesses, 325,000 hospitalizations, and 5,000 deaths due to foodborne illnesses. ... |
| Maximising the Drug Lifecycle |
|
| Published : 2001/08 |
| Up to $100bn of the 2000 pharmaceutical market, including blockbuster drugs with combined sales of $34bn will be exposed to generic competition by 2005. ... |
| Biomass Markets & Technology: An Opportunity for the 21st Century |
|
| Published : 2001/07 |
| Biomass Markets and Technologies, reveals what the future holds for this renewable energy source that has the potential to replace oil products to heat buildings, to fuel vehicles and to serve as a raw material in the chemical industry. ... |
| The Drug Delivery Outlook 2001 |
|
| Published : 2001/07 |
| In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery. ... |
| In-Vitro Diagnostics |
|
| Published : 2001/06 |
| US demand for in vitro diagnostic (IVD) reagents and instrumentation is expected to reach $12.2 billion in 2005. ... |
| Pharmaceutical/Biotech R&D Alliances |
|
| Published : 2001/06 |
| Build and Manage Collaborative Research Across Corporate, Government and Academic Boundaries to Increase Productivity and Minimize Risk ... |
| Commercial Biotechnology Review |
|
| Published : 2001/04 |
| No longer does the biotechnology revolution have to explain its value, as it did in the beginning. Today the results are tangible? With significant product sales, a record number of new products in the pipeline, and a breathtaking array of basic discoveri ... |
| The Surging Microarray Biochip Business |
|
| Published : 2001/04 |
| The goal of this market research study is to determine the present market for microarray biochips, arrayers, scanners and microfluidics chips, and to predict the future revenues worldwide ... |
| Predictive Toxicology (3 volume set) |
|
| Published : 2001/02 |
| AdvanceTech Monitor (ATM) reports give you a unique advantage. Not only do you receive over 20 chapters of expert opinion on the technology and business strategies behind Predictive Toxicology, ... |
| Proteomics: Analysis of Selected Emerging Technologies |
|
| Published : 2001/01 |
| This report forecasts how proteomics-the study of protein expression and function--will most successfully be used in drug development and how its various tools and approaches will evolve. Many companies, including Incyte and Amgen, are covered. ... |
|
|
Top
View Cart